Please assess the completion status of the following clinical trial:

Trial Title: Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Caucasian Argentinean males and females volunteers aged 21 to 50 years with a body mass index from 19 to 27 kg/m2 were enrolled in this study.~* All volunteers provided written informed consent prior to study initiation.~Exclusion Criteria:~* History of cardiovascular, hepatic, renal, psychiatric, neurologic, hematologic, or metabolic disease~* Drug or alcohol abuse within 2 years before the start of the study~* Smoking~* HIV, hepatitis B, or hepatitis C infection~* Consumption of any prescribed or over-the-counter drug within 2 weeks before the study or~* Participation in a similar study within the past 6 months. Female subjects were not to be pregnant, planning to become pregnant, or breastfeeding at the time of the study, and were required to use an effective method of contraception (intrauterine device or hormonal method) throughout the study.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Levodopa + benserazide (test formulation) (Type: EXPERIMENTAL): A randomized-sequence, open-label, 2-period crossover study assessing relative bioavailability of two drug products containing the association levodopa + benserazide.
- Levodopa + benserazide (reference formulation) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).